All Indications Are CMS Plans to Launch its 340B Drug Acquisition Survey on Monday

Editor’s note, March 20, 2020: When we published Tweets of Note yesterday, we were unaware of health care economist’s Rena Conti’s March 14 reply to a critic’s tweet the same day. We have added it to this web version of

Read More »

For Now, HRSA Doesn’t Plan to Change Its April 340B Registration Period

For Now, HRSA Doesn’t Plan to Change Its April 340B Registration Period

With health care providers bracing for COVID-19’s full force, the Health Resources and Services Administration (HRSA) at this time does not plan

Read More »

HRSA Tells COVID-19 Responders Concerned About 340B Compliance to Contact it Directly

HRSA Tells COVID-19 Responders Concerned About 340B Compliance to Contact it Directly

The Health Resources and Services Administration (HRSA) is advising health care providers concerned about whether

Read More »

Congressional Medicare Advisers Say 340B Has Minor Effect on Cancer Drug Spending and Patient Cost-Sharing

Congressional Medicare Advisers Say 340B Has Minor Effect on Cancer Drug Spending and Patient Cost-Sharing

Do 340B drug discounts induce hospitals to furnish more-expensive drugs to treat cancer than they otherwise would, raising patients’ coinsurance obligations and the cost of

Read More »

HRSA: 340B Dispute Resolution Will Stay on Hold Until We Get Broader Regulatory Authority

Editor’s note: The Medicare Payment Advisory Commission (MedPAC) is expected to report to Congress tomorrow that 340B’s effects on Medicare Part B beneficiaries’ cost sharing is likely small and varied across patients. We’ll publish an article about the findings and

Read More »

Hospital Groups to OMB: Quash 340B Hospital Drug Acquisition Cost Survey

Hospital Groups to OMB: Quash 340B Hospital Drug Acquisition Cost Survey

Groups representing 340B hospitals urged the White House yesterday to quash a planned survey due to

Read More »

DOJ Says Mallinckrodt Owes Medicaid Hundreds of Millions in Rebates, but Is Silent About 340B Overcharges

DOJ Says Mallinckrodt Owes Medicaid Hundreds of Millions in Rebates, but Is Silent About 340B Overcharges

The U.S. Justice Department is suing drug manufacturer Mallinckrodt for allegedly

Read More »

340B Providers Could Face Drug Access Challenges Due to Coronavirus

340B Providers Could Face Drug Access Challenges Due to Coronavirus

In theory, federal law and 340B program guidance should protect 340B entities from shouldering an unfair

Read More »

Update: 340B-Related Action in the States

Editors’ note: Have you read our 13-page special report on the 340B Coalition Winter Conference? We’ve received excellent feedback and think you and your colleagues will find it beneficial. Let us know what you think. Write to us at

Read More »

Welcome To 340B Report From Publisher & CEO Ted Slafsky

Dear Friends and Colleagues,

In addition to my role as Founder of Wexford Solutions, I am very pleased to announce the launch of a new venture—340B Report. 340B Report is the only independent subscription news service that provides regular

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report